Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Authors
Keywords
-
Journal
NATURE
Volume 601, Issue 7891, Pages 110-117
Publisher
Springer Science and Business Media LLC
Online
2021-11-11
DOI
10.1038/s41586-021-04186-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
- (2021) Anthony T. Tan et al. Cell Reports
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
- (2021) Catherine J. Reynolds et al. Science Immunology
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
- (2021) Charlotte Manisty et al. EBioMedicine
- Differential T cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers
- (2021) Ricardo da Silva Antunes et al. JOURNAL OF INFECTIOUS DISEASES
- RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
- (2021) Taisho Yamada et al. NATURE IMMUNOLOGY
- Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
- (2021) Fan Yang et al. SCIENCE
- Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
- (2021) Gabriele Pollara et al. Science Translational Medicine
- T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
- (2021) Ane Ogbe et al. Nature Communications
- Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection
- (2021) Luke Muir et al. Kidney International Reports
- SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
- (2021) Alba Grifoni et al. Cell Host & Microbe
- Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine
- (2021) Valerie Oberhardt et al. NATURE
- Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
- (2021) Lucie Loyal et al. SCIENCE
- CD8 + T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
- (2021) Vamsee Mallajosyula et al. Science Immunology
- Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
- (2021) Cedric C.S. Tan et al. INFECTION GENETICS AND EVOLUTION
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- COVID-19: PCR screening of asymptomatic health-care workers at London hospital
- (2020) Thomas A Treibel et al. LANCET
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein
- (2020) Andrew P. Ferretti et al. IMMUNITY
- Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2
- (2020) Marina Johnson et al. JOURNAL OF CLINICAL VIROLOGY
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
- (2020) Annika Nelde et al. NATURE IMMUNOLOGY
- Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
- (2020) Stefania Capone et al. npj Vaccines
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2 antibody responses in patients with acute leukaemia
- (2020) J. O’Nions et al. LEUKEMIA
- Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
- (2020) Carlo Cervia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
- (2016) Jincun Zhao et al. IMMUNITY
- Human T cell responses to Japanese encephalitis virus in health and disease
- (2016) Lance Turtle et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity
- (2013) Jens M. Werner et al. GASTROENTEROLOGY
- Occupational Exposure to Hepatitis C Virus: Early T-Cell Responses in the Absence of Seroconversion in a Longitudinal Cohort Study
- (2013) Theo Heller et al. JOURNAL OF INFECTIOUS DISEASES
- SPICE: Exploration and analysis of post-cytometric complex multivariate datasets
- (2011) Mario Roederer et al. CYTOMETRY PART A
- Coronaviruses post-SARS: update on replication and pathogenesis
- (2009) Stanley Perlman et al. NATURE REVIEWS MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started